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ABSTRACT 
Background: Pediatric chronic pain affects between 11 and 38% of all children. Although 
pain may result from injury or disease, the cause of chronic pain is commonly unclear. The 
interaction between biological, psychological, and social aspects has been emphasized as 
key to the understanding of the chronic pain experience, as well as risk and resilience 
factors. Pediatric chronic pain may result in significant impairment affecting both child and 
family functioning, and addressing family factors such as parental distress and protective 
behaviors, are generally considered important to pediatric chronic pain management. 
However, there is still a need to identify resilience factors that can be targeted in parental 
support programs, and to develop and evaluate effective parent support interventions. The 
complexity of the pain experience in pediatric chronic pain is well known with a large 
number of patients suffering from co-occurring disorders such as depression or insomnia. 
However, despite a considerable number of clinical observations suggesting an elevated 
prevalence of attention-deficit hyperactivity disorder (ADHD) and autism spectrum 
disorder (ASD) among children with chronic pain, and similarities in terms of clinical 
correlates, the empirical support has been scarce. More research on the co-occurrence of 
pediatric chronic pain, ADHD, and ASD, including relationships with functioning, is 
therefore warranted.  
 
Purpose and aims: The purpose of the present research project was to identify and assess 
parental and child factors of importance for functioning and treatment effects in pediatric 
chronic pain. More specifically, the aims of the project were to: validate an instrument for 
parental psychological flexibility (Study I); evaluate the effects of a brief parental ACT-
intervention on parent outcomes (Study II); assess the prevalence of clinically significant 
traits and symptoms of ASD and ADHD in children, and relations to pain- and 
demographic variables (Study III); and, to explore the relationships between traits and 
symptoms of ASD and ADHD, functioning, and health-related quality of life (HRQoL) 
(Study IV). 
 
Methods: In Study 1, utilizing a cross-sectional design, the Parent Psychological 
Flexibility Questionnaire (PPFQ) was translated and psychometrically evaluated in a 
sample of parents (n=263) of children with chronic pain using principal component analysis 
(PCA), correlation and regression analyses, and analysis of internal consistency. In Study 
II, the effects of individual and group ACT-interventions for adolescents (n=48) with 
chronic pain, and a brief support program for their parents (n=28), were evaluated using a 
randomized (group/individual) uncontrolled pilot design and non-parametric analyses of 
differences between groups and over time. In Study III, the prevalence of clinically 
significant ASD-traits and ADHD-symptoms was evaluated in a descriptive cross-sectional 
study on children with chronic pain (n=146) and their parents (n=146). Differences in pain- 
and demographic variables between children below and above cutoff for clinically 
significant traits and symptoms of ADHD or ASD were also assessed. Study IV, using the 
same sample as Study III, examined the relationships between ASD-traits and ADHD-
symptoms, functioning (depression and pain interference), and HRQoL in correlation- and 
regression analyses and with independent t-tests, and assessed the indirect effects of 
insomnia and psychological inflexibility on the relationships between ASD-traits or 
ADHD-symptoms as predictors and functioning and HRQoL as dependents. 
 
Results: In Study 1, results supported a three-factor solution for the PPFQ with 10 items 
(PPFQ-10), showing good internal consistency and explaining a significant amount of 
 variance in the criteria variables anxiety (29%) and depression (35.6%). In Study II, 
significant improvements in parental pain reactivity and psychological flexibility were 
found with clinically significant changes in the direction of better functioning for 54-76% 
of parents, with no differences between individual and group formats. In Study III, 13.7% 
of the sample presented with clinically significant ASD-traits and 19.9% of the sample 
presented with clinically significant ADHD-symptoms. The combined prevalence of 
clinically significant ASD/ADHD-traits and symptoms was 26%. Children with clinically 
significant ASD-traits were more likely to be girls and clinically significant ADHD-
symptoms showed no gender differences. In Study IV, children with clinically significant 
ASD-traits and ADHD-symptoms presented with significantly higher levels of depressive 
symptoms and pain interference, and significantly lower HRQoL, compared to the rest of 
the sample. ASD-traits and ADHD-symptoms explained a significant amount of variance in 
pain interference and depressive symptoms, as well as in HRQoL. Psychological 
inflexibility was shown to mediate the influence of both ADHD-symptoms and ASD-traits, 
and insomnia the effect of ADHD-symptoms, on depression, pain interference, and 
HRQoL. 
 
Conclusions: Although tentative, the results suggests the utility of addressing parental 
psychological flexibility in relation to pediatric chronic pain. However, more research is 
warranted and future studies should e.g. evaluate the predictive utility of the PPFQ for child 
treatment outcomes, and evaluate if parental support programs that increase parental 
psychological flexibility also have positive effects on the children. Also, the results provide 
empirical support regarding elevated levels of clinically significant ADHD-symptoms and 
ASD-traits in pediatric chronic pain, and illustrate significant relationships between such 
traits and symptoms and functioning in children. Children with debilitating chronic pain, 
particularly girls, may be at risk for having a comorbid, and possibly undetected high-
functioning neurodevelopmental disorder. Results thus suggest the utility of screening for 
neurodevelopmental disorders in children with chronic pain, and may indicate insomnia, 
and psychological flexibility as potential treatment targets to improve functioning and 
HRQoL. The results also warrant further research to e.g. validate these findings in larger 
studies, evaluate the utility of tailored interventions, and examine the shared 
neuropathophysiology of chronic pain and neurodevelopmental disorders, including 
dopamine function and sensory abnormalities. 
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 1 
1 INTRODUCTION 
 
What is pediatric chronic pain and who has it? Despite being a major health problem, many 
questions regarding the experience of pain, the possible existence of an overall clinical 
phenotype in pediatric chronic pain, and how to effectively treat it, still remain unanswered. 
During my years working as a clinical psychologist with children1 suffering from chronic 
pain and their parents at a tertiary pain clinic, I have seen the debilitating effects of chronic 
pain up close in its many different expressions, but also with important similarities across 
the patients and their parents. In my clinical work, it became increasingly clear that 
pediatric chronic pain is not primarily a condition that resides within the individual, but 
occurs in, and interacts with, a larger context such as family, parents, friends, and school.  
Based on my previous work with assessment and screening of attention-deficit 
hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), I observed in some of 
our chronic pain patients what I perceived were traits and behavioral difficulties indicative 
of ADHD and high functioning ASD. Over time, my impression was that the occurrence of 
these manifestations was relatively larger among our pediatric pain patients, than the 
normal prevalence of these disorders. In terms of clinical manifestations, in particular one 
child with severe chronic pain and comorbid ADHD and ASD [1], sparked a sense of 
urgency and interest in finding out more about the prevalence of neurodevelopmental 
disorders in pediatric chronic pain, and any relationships with functioning. 
 
A clinician at heart, I have, with the support and encouragement of dedicated and 
knowledgeable colleagues and faculty funding, been given the opportunity to study these 
topics related to the context of pediatric chronic pain. In relation to the larger context, by 
studying aspects of parental functioning; and in relation to the individual, by studying the 
prevalence of traits and symptoms of ADHD and ASD in children, and relationships with 
functioning. Albeit a modest contribution to a large picture puzzle, it is my hope that my 
research will be of relevance in further development of methods to help children and 
adolescents that suffer from chronic pain. 
 
 
Stockholm, January 2019 
 
 
 
 
 
  
                                               
1 The terms "child" and "children" here and throughout also includes adolescents (up to the age of 18), unless 
detailed specification is required or given.   
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2 BACKGROUND 
2.1 PEDIATRIC CHRONIC PAIN 
Chronic pain in children, most often defined from a temporal point of view as pain that 
persists or recurs for more than (usually) three months, may arise as a result of a chronic 
health condition, such as e.g. arthritis or sickle cell disease [2]. However, in the context of 
pediatric chronic pain, the terms functional and idiopathic are also well known and 
typically refer to a situation where the biological origin or pathophysiological mechanism is 
unclear [3, 4].  
 
The many pain sub-diagnoses (e.g. chronic daily headaches, functional abdominal pain, 
fibromyalgia, etc.) that are fitted under the diagnostic umbrella of functional pain disorders 
(FPD) further reflect the heterogeneity of the pain expressions and possibly also the 
diagnostic uncertainty embedded in the FPD-label [5, 6]. Regardless of classification, 
however; functional, unexplained, or idiopathic pain, affects many children, as noted by 
several studies [6-8], but specific epidemiologic data on the broader construct of FPD is 
scarce, in part likely due to the uncertainty regarding a clear operationalization of overall 
FPD [9].  
2.1.1 Definition and conceptualization of chronic primary pain - a 
classification for a "new" era 
In 2016, a Task Force appointed by the International Association for the Study of Pain 
(IASP) and the World Health Organization (WHO), suggested a new systematic 
classification of chronic pain for the 11th revision of the International Classification of 
Diseases (ICD-11) [10] that has now been incorporated into the new ICD-11 under the 
label “Chronic primary pain” (CPP), with an appending classification just recently (January 
2019) released by Nicholas et. al. [11]. In accordance with the previous definition of 
chronic pain [2], it is suggested that chronic pain should be defined as persistent or 
recurrent pain, lasting longer than 3 months. However, and different from the old 
perspective, the proposed CPP-diagnosis does not classify pain as defined by either a 
pathophysiological-, or a psychological cause. Instead, CPP is conceptualized as a complex 
disease with psychological, biological, and social factors interacting to produce the chronic 
pain experience [11]. This corresponds with the widely recognized biopsychological model 
of chronic pain [12], and is sensible also to the immediate patient-caregiver relationship, 
where e.g. parents of children with chronic pain have been found to perceive the lack of a 
clear pathophysiological mechanism as more worrisome when psychological reasons for 
pain are presented as the only alternative to pathophysiology [13].  
 
Besides the three-month duration of pain in one or more body regions, the ICD-11 
classification also specifies in the definition of CPP, that pain should not be better 
explained by another diagnosis, and that it should be "associated with significant emotional 
distress (...) and/or significant functional disability". These last specifications are important 
additions that are in accordance with the statements by the Pediatric Initiative on Methods, 
Measurement and Pain Assessment in Clinical Trials (PedIMMPACT), declaring emotional 
functioning, physical functioning, and pain intensity as three of the primary outcome 
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variables to assess in clinical trials on pediatric chronic pain [14]. Several epidemiological 
studies on pediatric chronic pain have for instance focused mainly on pain symptoms and 
not on functional impairment, which may in turn limit the ability to generalize other 
findings from these studies to more severely impaired groups [15]. Also, such focus on 
symptoms does not seem to be in line with actual and recommended clinical practice for 
pediatric chronic pain, that usually employs a multidisciplinary targeting of several aspects 
of the chronic pain experience [16, 17], and may hamper the evolution towards a broader 
understanding of chronic pain in children. It is possible that this new classification may also 
aid in generating more consistent prevalence findings in epidemiological, as well as clinical 
studies on pediatric chronic pain, by encouraging new methodological approaches.    
2.1.2 Prevalence 
Several studies have sought to examine the overall prevalence of chronic pain in children, 
and have found it to be a common problem that appears to be increasing [18-21]. The 
American Pain Society estimates that between 20% and 35% of children around the world 
are affected by some type of chronic pain [22].  In the comprehensive review by King et al. 
(2011) [18] on the epidemiology of pediatric chronic pain, and a follow up summary in the 
Encyclopedia of Pain (2013) [23], the overall prevalence of pediatric chronic pain was set 
at between 11 and 38%. Prevalence rates, however, differed significantly between studies, 
many studies did not meet quality criteria, and there was a large variation in the 
methodology used, which made truly meaningful comparisons and syntheses difficult. 
Headaches, abdominal pain, and musculoskeletal pain were among the most common pain 
types (with headache being the most common). Notably, overall, the reported prevalence 
rates ranged between 8–83% [18]. For most pain types, although not abdominal pain, the 
pain prevalence increased with age [18]. Another large international study on the 
prevalence of chronic pain in adolescents by Swain et al. (2014) [24] found a similar 
pattern with headache being the most common pain type along with high prevalence 
numbers for abdominal and back pain, and many participants reported multi-site pain, with 
the highest odds of experiencing an additional pain found for headache and abdominal pain 
[24]. Overall, prevalence ranged between 37 - 54% for the various pain types (sites), 
however, the prevalence of children who experienced daily pain episodes was between 4 - 
8% across all pain sites [24]. Concerning the separate study of the prevalence of idiopathic 
chronic pain, some attempts exist, including a Norwegian study in 7373 adolescents, of 
which 44.4% reported idiopathic chronic pain, 10.2% described daily (or almost daily) 
idiopathic pain, and 25.5% reported multi-site idiopathic pain [25]. 
 
In conclusion, precise and instructive estimates of pediatric chronic pain prevalence depend 
on definitions, which implies the relevance of operationalizing e.g. temporal and locational 
aspects of pain (duration, frequency, sites), as well as pain interference, which is a critical 
but still somewhat neglected dimension within prevalence research on pediatric chronic 
pain [23]. 
2.1.3 Gender differences 
Chronic pain appears to be more common in girls than in boys in community as well as 
clinical samples [18, 21, 23, 26, 27]. In terms of pain location, this pattern also holds true, 
with a female-biased incidence for most pain sites [23]. Adolescent girls have also been 
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shown to report more multi-site pains [24]. Higher rates of pain and associated disability 
are seen in girls than boys [25, 28], as well as higher levels of anxiety sensitivity and pain 
catastrophizing [29, 30]. The reasons for these gender differences have not been clearly 
established. Catastrophizing has e.g. been associated with a higher degree of overt pain 
behavior in the social context and it has been suggested that this may illustrate a relevant 
gender aspect as girls have been found to express more overt pain behavior than boys, 
which may in turn lead to e.g. more pain reinforcing behaviors from others, including 
parents [31]. From the biological perspective, a recent study found chronic nonspecific pain 
to be more prevalent among girls with early menarche, than in those with normal, late, or 
no menarche [32], and early puberty has also previously been associated with more back 
pain in girls [33]. On a related note, it has previously been shown that the sex hormones 
estrogen and testosterone affect the chronic pain experience [34], and low testosterone 
levels have been associated with a higher risk for chronic pain in both mice and human 
models, where testosterone therapy was shown to affect central sensitization and decrease 
the pain response in women with fibromyalgia [35].  
2.1.4 The biopsychosocial model of chronic pain  
The biopsychological model of chronic pain constitutes an important frame of reference for 
understanding the role and function of both internal and external contextual factors in the 
development, experience, and chronification of, and disability in, pediatric chronic pain 
[12]. Hence, it serves as an important foundation for designing the pain assessment and 
interpreting the findings, as well as for the formulation of individualized multimodal 
treatment options [36, 37]. 
 
Figure 1. A simplified illustration of the biopsychosocial model of chronic pain. 
 
In the model, pediatric chronic pain is conceptualized as the product of a number of 
processes of biological, social, and psychological character [12], including mood, 
catastrophizing, cognition, neuroplasticity and structure, family, parents, friends, and 
Chronic 
pain
Biological 
factors
Psychological 
factorsSocial factors
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school, etc. [36, 38]. In the following sections, some of these factors will be addressed in 
relation to pediatric chronic pain. 
2.1.5 Parental and family factors 
There is accumulating evidence that family factors, such as family functioning, parental 
distress, and parent behavior are of paramount importance in order to understand the 
development and persistence of pediatric pain [39-42].  
 
Poor family functioning in pediatric chronic pain has been associated with high-conflict 
interactions within the family, low parental ability to engage in adaptive behaviors, and 
poor emotion regulation in parents [40, 42]. Furthermore, poor family functioning is more 
prevalent compared to families with healthy children [40, 43], and has also been linked to 
more functional disability in the child with chronic pain, including school absence and 
lower overall activity [42].  
 
Moreover, there is increasing evidence describing the association between functional 
disability in children with chronic pain, and parental distress, including anxiety, pain 
catastrophizing, and depression [41, 44, 45]. For example, in one longitudinal study [46], 
the distress and avoidances behaviors of parents were shown to significantly predict child 
emotional- and school functioning 4 months after a multidisciplinary intervention. The 
inclusion of parental characteristics and behaviors in the assessment and treatment of 
children with chronic pain, therefore seems to be highly important to inform effective 
treatment options for the child [22, 46]. 
 
It is also common that parents of children with chronic pain suffer from chronic pain 
conditions themselves [47], and parents’ own pain has been associated with an increased 
risk for anxiety and depression in children with chronic pain [48], as well as poorer 
outcomes than other children with non-afflicted parents in a number of areas, including 
coping [49].  
 
Finally, research on shared family factors, such as genetics and family physical 
environment, have found some evidence of genetic risk factors for chronic pain [50], and 
some shared effect of environment [51]. Notably, however, the largest amount of variance 
was found to be explained by factors pertaining to the specific individual circumstances 
[51]. 
2.1.6 Comorbid mental health conditions 
Psychiatric disorders are common in pediatric chronic pain [8, 52], and in particular in 
functionally impaired samples. A large study on an inpatient sample of children with 
chronic pain, e.g. found the prevalence of comorbid psychiatric diagnoses to be 44% [53]. 
 
In particular anxiety and depression have shown strong associations with chronic pain in 
children [54], along with post-traumatic stress disorder (PTSD) [55]. Depression has been 
strongly associated with functional disability and maladaptive coping [56], and anxiety has 
been shown to robustly predict school functioning over and above pain intensity [57]. 
Research further indicates that anxiety disorders may predate the onset of pain and thus 
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serve as a risk factor for the development of chronic pain [58, 59]. High anxiety has further 
been observed to "override" the association between pain intensity and functional disability 
as shown in one study where pain intensity predicted functional disability in the presence of 
low anxiety but not in the presence of high levels of anxiety [60]. Chronic pain in 
adolescence has also been associated with an increased risk for anxiety to persist into 
adulthood [61]. 
 
Also, although not considered a mental health disorder but rather a personality trait, higher 
levels of the inability to recognize and express own feelings (poor emotional awareness), 
known as alexithymia, have been found in children with chronic pain [62-64]. Alexithymia 
appears to be associated with anxiety and depression in chronic pain [62], and overall with 
an increased physiological arousal that is hypothesized to contribute to the onset of medical 
comorbidities [65]. The relationships between chronic pain and alexithymia, including 
implications for assessment and treatment in pediatric chronic pain, have however not been 
clearly established [62, 64]. 
2.1.7 Sleep disturbances 
Much like pediatric chronic pain, pediatric sleep disturbances, including sleep 
deprivation/shorter periods of sleep (insomnia), comprise a variety of dysfunction-patterns 
and include several categories and subcategories of (sleep) disorders [66, 67], and is more 
prevalent among females [68]. Like chronic pain, sleep disturbances may also be 
conceptualized as the main disorder or as concurrent to another disorder [67]. The crucial 
importance of sleep for several aspects of child development has been shown in many 
studies [66, 69], including for mental health and physical growth, as well as immune system 
function and neurodevelopmental processes [70]. One study on healthy children (ages 5-12) 
showed a particularly heightened sensitivity in developing brain circuits to restrictions in 
sleep different from that of adults, indicating the importance of sleep for the maturing brain 
plasticity [71].  
 
The importance of evaluating and treating sleep disorders is continuously being emphasized 
in the context of pediatric chronic pain [37, 72-74], where research shows that sleep 
disturbances are common [75]. The incidence of sleep disturbances in adolescents in 
chronic pain treatment has been found to be nearly six times higher than that of healthy 
adolescents [73], and one study on children with chronic pain presenting for tertiary pain 
care found distorted sleep in 74% [76]. Sleep disturbances have also, in a number of studies 
on children with chronic pain, been associated with functional disability in terms of 
interference with daily-life activities such as school-functioning [27, 77, 78]. In a recent 
study [79] on a tertiary pain care sample of children with chronic pain in the ages 10-17, 
poor sleep was also found to mediate the relationship between PTSD symptoms on the one 
hand, and pain interference and pain intensity on the other. The authors concluded that 
sleep may be a potentially important treatment target, especially for children with chronic 
pain that do not respond well to standard pain treatments [79].  
 
Whether chronic pain on an overall level causes sleep disorder or vice versa does not seem 
to be easily answered. Instead, there seems to be a reciprocal relationship between these 
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disorders, with one influencing the other over time due to biological as well as 
psychological and social circumstances [37]. Thus, adequate sleep could be an important 
factor of strength in responding to the challenges in pediatric chronic pain, which is 
supported by studies illustrating that good sleep is a factor of longitudinal resilience in 
other pediatric populations [80].  
2.1.8 Neurobiological processes  
In the following section, some of the main neurobiological processes that have been 
implicated in chronic pain are discussed; the coverage, however, does not attempt to be 
exhaustive.  
 
There is emerging evidence that neural plasticity, that is, the brain’s ability to change and 
adapt to new circumstances throughout the lifespan of a person, may provide an integral 
part as a mechanism involved in development of persistent pain even without the presence 
of acute pathophysiology [81]. One form of dysfunctional neuroplasticity is central 
sensitization where, due to maladaptive neural learning processes, the sensitivity to pain 
signaling is increased in the central nervous system (CNS), with or without the (continued) 
presence of input from peripheral neurons (e.g. tissue damage) [82]. Central sensitization is 
present in several chronic pain conditions, including fibromyalgia and musculoskeletal 
pain [83]. Central sensitization furthermore appears to be associated with emotional state 
[84], e.g. in adolescents with fibromyalgia [85], and may involve a form of continuous 
neural self-reinforcement where pain eventually gets stuck within the CNS [82, 86].  
 
Neuroinflammatory processes (brain- and spinal cord glial cell-induced release of 
proinflammatory cytokines) has been implicated as one of the driving forces behind central 
sensitization [87]. In recent studies, central cytokines have been found to function as 
neuromodulators (through the secretion of molecules that affect e.g. the neuron's regulation 
of pain) in both the CNS and the peripheral nervous system [87, 88]. In either system, 
cytokines may hence activate heightened pain sensitivity (allodynia) or pain insensitivity 
after having been released into the CNS [87]. If this process of cytokine release is sustained 
in the CNS, it may promote multi-site chronic pain [87, 88].  
                      
In the CNS, a stress response is handled by the autonomic nervous system and the 
hypothalamic-pituitary adrenal (HPA) axis in concert. Activation of the HPA-axis results in 
secretion of cortisol, and activation of the sympathetic branch of the autonomous system 
results in secretion of epinephrine and norepinephrine [89]. These systems have 
complementary functions in the body, and work jointly to make energy available and to 
increase blood pressure. In the face of challenges, the adaptive response of these systems is 
to promote stress-adaptive behavior and to reinstate homeostasis. Regulation of the HPA 
axis in healthy states rely e.g. on negative feedback and sensitivity to increased levels of 
e.g. cortisol [89]. HPA-dysregulation in chronic pain has been indicated in several studies 
where this process of cortisol back-signaling was indicated to be disrupted along with non-
normal (both higher and lower than normal) levels of cortisol [55, 90-93].  
 
Dopamine is a neurotransmitter that affects a number of functions including, but not limited 
to, cognition, sleep, and pain processing in terms of e.g. involvement in endogenous pain 
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modulation, according to preliminary evidence [94]. Chronic pain (e.g. fibromyalgia) has 
been associated with impaired dopamine function (hypodopaminergic state) in a number of 
clinical- and preclinical studies [86, 95-98] which in individuals with chronic pain has been 
associated with increased pain sensitivity and reductions in reward-driven behavior, i.e. 
performing behaviors that under normal-state circumstances would be positively reinforced 
[86, 98]. 
 
Based on the above findings it may be concluded that several neurobiological processes are 
involved in the experience of chronic pain, and, tentatively, findings could indicate that, 
much like on the behavioral level, also on a neuronal level, maladaptive learning processes 
and (neural) "rigidity" (as the opposite of high neural plasticity) appear to be associated 
with chronic pain. 
2.1.9 Summary notes on risk and resilience factors in relation to impaired 
functioning in pediatric chronic pain 
In the previous sections, some of the social, psychological, and biological factors that are 
associated with the presentation and experience of pain and functioning in pediatric chronic 
pain have been presented. On a summary note on functioning, research shows that pediatric 
chronic pain conditions may lead to severe impairment and disability in subsamples of 
affected individuals in both community and clinical samples [25, 27, 99]. Lower school 
attendance, less social engagement and peer-interaction, restrictions in physical activities, 
and sleep disturbances are functional impairments frequently associated with chronic pain 
in children [42], confirming the notion of chronic pain as a significant health problem [99, 
100]. Moreover, in research on health-related quality of life (HRQoL) in chronic pediatric 
pain, children report significantly lower HRQoL than children with other chronic 
conditions and healthy children [101].  
 
As mentioned in the above sections, several factors contribute to an increased risk for 
functional impairment in pediatric chronic pain [102]. Factors related to the individual, 
such as gender and biology (stress and pain response), pain catastrophizing, mental state, 
pain intensity and location, and poor sleep have been consistently related to higher levels of 
disability, along with factors related to the larger context of the individual, such as low 
family cohesion, parental anxiety, and depression [25, 31, 42, 57, 103]. 
 
In general, the body of research on resilience factors in pediatric chronic pain is small and it 
has been suggested that an increased focus on factors of strength could contribute in 
moving the field forward [104], On an overall level, high self-respect, meaningful and 
supportive relationships with peers, a sense of family bond, and social competence, are 
factors that have been associated with better functioning in pediatric chronic pain [42, 105-
107]. 
 
Finally, on a note on methodology; in some epidemiological studies conducted among 
community- and school samples, the portion of severely impaired individuals (e.g. with 
daily pain episodes and related disability) may de facto be very small [21, 108].  This may 
 10 
further reduce the ability to generalize such findings on e.g. pain disability to more severely 
impaired groups [15]. 
2.2 TREATMENTS FOR PEDIATRIC CHRONIC PAIN 
2.2.1 Pharmacological treatment 
There is a lack of randomized controlled trials for the use of pharmacological therapies in 
pediatric chronic pain [109]. While usually very effective in the treatment of acute pain, 
pharmacological treatments in isolation, however, have been reported to have a limited 
effect on pediatric chronic pain, and appear, on occasion, to be used by pediatric chronic 
pain patients without indication [15]. There are furthermore large differences among 
children in terms of who will respond to a certain pharmacological treatment and, overall, 
the use of such treatments are nowadays mostly recommended solely within the frame of 
multimodal treatment, in combination with e.g. psychological treatment interventions [110].  
2.2.2 Psychological interventions  
2.2.2.1 Cognitive behavioral therapy (CBT)  
CBT is comprised of a number of behavior-psychological interventions with strong 
empirical support in a large number of therapeutic areas [111]. With a foundation in 
learning theory, the goal of CBT is to improve functioning trough behavior change and 
change of thinking patterns that are not adaptive [112].  
 
In chronic pediatric pain management, psychological interventions are common, usually 
incorporated within a multidisciplinary treatment approach [17], and frequently based on 
CBT [113]. Although many studies on psychological interventions (CBT), exist, the 
evidence of efficacy does not match the amount of studies [113]. A number of systematic 
reviews [114-117] on psychological interventions in pediatric chronic pain, including both 
in person- and remotely delivered formats, show that psychological interventions deliver 
promising results but merely in the short term [113, 114]. Furthermore, CBT-treatments 
seem to lack in specificity in terms of treatment content, reducing the possibility for 
replication as well as the understanding of effective components [114]. In terms of evidence 
for outcomes other than pain, such as anxiety, depression, and sleep, such factors have 
often not been included [113]. 
 
In line with research on the importance of parental factors, parents are also frequently 
included in psychological treatments for pediatric chronic pain; however, the relation 
between parental involvement and child functional outcomes has not been satisfactorily 
established [115], and efficacy of interventions in terms of parent outcomes is either 
lacking or has generally not been maintained over the long term [118]. Studies on CBT for 
chronic pain that e.g. evaluate sleep as well as parental mood factors, are however emerging 
[119, 120]; in one study, parental anxiety, depression and pain catastrophizing was found to 
predict child disability [120], providing further evidence regarding the importance of 
assessing and treating parental factors in pediatric chronic pain.  
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2.2.2.2 Acceptance and Commitment Therapy (ACT) 
ACT is a psychological therapy developed within CBT that integrates processes of 
acceptance and mindfulness with behavioral change. As an extension of learning theory, the 
theoretical underpinning of ACT is Relational frame theory (RFT), a theory of language 
and thinking [121]. RFT aims to apply learning theory to verbal behaviors, to better 
understand how the process of using language, like any behavior, is shaped through 
reinforcement and thus may introduce a rigidity (or flexibility) in thinking depending on the 
individual circumstances. Words and thinking thus constitute stimuli that; first, are 
activated in the presence of certain circumstances (e.g. pain); and second, like any stimuli, 
may activate reinforced behavioral "protocols", with the function of e.g. avoidance [121]. 
The goal of ACT is increased psychological flexibility, which is conceptualized as the 
ability to act according to long term values and goals also in the presence of aversive 
interfering stimuli such as pain or distress [122]. Psychological flexibility has also been 
described as a “fundamental aspect of health”, with presumably high relevance to other 
constructs such as executive function [123].   
 
In ACT-treatment for pediatric chronic pain, the objective is to promote a more values-
consistent behavioral repertoire in the presence of pain; e.g. attending school and meeting 
friends both when pain is low and high. Exposure, to actively engage in behaviors that 
increase pain or distress but are valued, is encouraged, and combined with acceptance 
strategies to enhance psychological flexibility [124]. Acceptance and level of functioning 
has been strongly associated in research on pediatric chronic pain [125], and ACT-based 
psychological treatments for pediatric chronic pain are gaining increasing and promising 
evidence [107, 126-128]. However, the need for larger studies with longitudinal designs, 
stringent methodology, and the inclusion of parents in treatment protocols has also been 
emphasized [124, 129].   
 
Research has also examined psychological flexibility among parents of children with 
chronic pain. Parental psychological flexibility is conceptualized as the parent's willingness 
to experience own distress for the purpose of pursuing long-term values and related goals, 
such as effectively assisting the child to manage his/her pain and distress in pursuing valued 
behaviors although this may cause own distress [130, 131]. Two studies have validated the 
Parental Psychological Flexibility Questionnaire (PPFQ) in samples of parents of 
adolescents with chronic pain. Results from both studies showed a positive relationship 
between the level of psychological flexibility in parents and the level of functioning in 
adolescents. Authors thus concluded that increasing psychological flexibility in parents of 
children with chronic pain could, in itself, be a potentially important treatment target with 
the potential of improving treatment effects for the child with chronic pain [130, 131].  
2.3 PEDIATRIC CHRONIC PAIN AND NEURODEVELOPMENTAL 
COMORBIDITY 
Autism spectrum disorder (ASD) is a neurodevelopmental disorder, or set of disorders 
(hence "spectrum"), characterized by deficits in communication and social interaction and 
restricted, repetitive behavior patterns and interests that cause impairment [132, 133]. The 
estimated prevalence of ASD in children in the normal population is 1.47% [134-137], and 
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ASD is more than twice as prevalent in boys [138]. Children within the ASD-spectrum may 
present with a high variability in difficulties, including intellectual disability (with or 
without), language impairment (with or without), and varying levels of sensory modulation 
difficulties [133, 139].  
 
The abnormal experience of sensory symptoms in ASD has in recent years been included as 
a diagnostic criterion of the disorder [133], appears to be common [140-142], and overall is 
gaining increasing interest in research [143]. Sensory symptoms in ASD frequently 
manifest in sensory modulation disorders (SMD) such as sensory under- and sensory over-
responsivity (SOR) [143]. SOR is generally described as an intense or exaggerated response 
to stimuli that are neutral [144], and has been strongly associated with anxiety [145], 
gastro-intestinal problems [146], and behavioral difficulties in children with ASD [147].  
 
Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder defined 
by a pattern of developmentally-inappropriate and impairing inattention, hyperactivity, and 
impulsivity [148]. The pooled estimated prevalence of ADHD in children in the normal 
population is 5.29% [149], and the disorder, like ASD, has a male-biased incidence, being 
twice as common in boys [150]. In children with ADHD, SOR is also highly prevalent and 
has shown strong associations with anxiety [151].  
 
Children with ASD or ADHD share several comorbid difficulties, including sleep disorders 
[152], executive function deficits [153], and mental health disorders [154], that are all 
highly prevalent in both disorders [155]. Moreover, ADHD and ASD frequently present 
together [156], and it has been suggested that ASD and ADHD, despite different clinical 
characteristics, may share brain pathology, including abnormalities in dopamine signaling 
affecting reward-driven behavior [155, 157-159]. Alexithymia, and the associated 
dysfunctions in emotional processing, is furthermore substantially elevated in children with 
ASD [160, 161], and has been tentatively associated with symptoms of hyperactivity and 
impulsivity in children with ADHD [162]. Finally, children with ASD or ADHD often 
present with immunological, neurological, and gastroenterological comorbidity [163, 164].  
2.3.1.1 Chronic pain and neurodevelopmental comorbidity 
Despite a large number of clinical observations, the prevalence of comorbid ADHD and 
ASD in pediatric chronic pain is yet unclear. Studies in patients with abdominal pain [146, 
165], a study on migraine [166], a study on neuropsychological function in pediatric 
chronic pain [167], and a number of case reports [1, 168-170], suggest a potential incidence 
of ASD and ADHD in pediatric chronic pain that may be larger than the normal prevalence 
of these neurodevelopmental disorders. Moreover, observations of children presenting with 
chronic medical conditions, indicate a possibly higher than normal incidence of 
neurodevelopmental comorbidity in these groups [163, 171, 172]. In summary, clinical 
observations, recent studies, and to some extent also similarities across clinical correlates, 
call for more research on the co-occurrence of pediatric chronic pain and 
neurodevelopmental disorders. 
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2.4 PHENOTYPING AND IMPLICATIONS FOR PRECISION-MEDICINE  
Clinical phenotyping is receiving increased attention in pediatric chronic pain research 
[173, 174]. Evaluating factors of relevance for the experience of chronic pain and disability 
as potential risk or resilience factors as they manifest in individuals, or groups of 
individuals, is implicated as essential to achieve better treatment effects and to refine 
theories, thus moving the field forward [86, 113]. The focus on phenotyping illustrates a 
transition from a broader focus on pain intensity and functioning, to potential treatment 
targets in more or less individually tailored interventions, also known as precision medicine 
[173].  
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3 PURPOSE AND AIMS OF THE THESIS 
The purpose of this research project was to identify and assess parental and child factors of 
importance for functioning and treatment effects in pediatric chronic pain. The overall aim 
was twofold; to investigate a) the role of parental psychological flexibility, including the 
effects of a brief parental ACT-intervention; and b) the prevalence of traits and symptoms 
of neurodevelopmental disorders in children and implications for functioning. The specific 
study aims are described below in detail. 
3.1 STUDY I 
The aim of Study I was to validate the Swedish version of the Parent Psychological 
Flexibility Questionnaire (PPFQ) in a sample of parents of children and adolescents with 
chronic pain, by evaluating the factor structure, reliability, and concurrent criteria validity. 
3.2 STUDY II 
The aim of Study II was to preliminary evaluate the treatment effects of an ACT 
intervention delivered in group or individually, including a brief parent support program, in 
a sample of adolescents with chronic debilitating pain and their parents. 
3.3 STUDY III 
The aims of Study III were 1) to investigate the prevalence of clinically significant ASD-
traits and ADHD-symptoms in children; and 2) to evaluate differences in parent/child 
demographic- and pain variables between children with and without clinically significant 
ASD-traits and ADHD-symptoms, in a sample of children and adolescents with chronic 
pain and their parents. 
3.4 STUDY IV 
The aims of Study IV were, in a sample of children and adolescents with chronic pain and 
their parents (same sample as Study III) 1) to examine the relationships between ASD-traits 
and ADHD-symptoms, functioning (depression and pain interference), and HRQoL; and 2) 
to assess the mediating function of insomnia and psychological inflexibility on the 
relationships between ASD-traits or ADHD-symptoms as predictor-, and HRQoL, 
depression, and pain interference as dependent variables. 
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4 METHODS 
4.1 OVERVIEW OF STUDY METHODS 
This thesis contains four studies conducted on clinical samples of children and adolescents 
with chronic pain and their parents, using three different data sets. One study used a 
randomized uncontrolled pilot design, where participants were randomized to individual or 
group treatment and assessed longitudinally pre-, mid- and post-treatment (Study II). The 
remaining three studies utilized a cross-sectional design, including a psychometric 
evaluation (Study I), a prevalence study (Study III), and a correlational study (Study IV). 
Studies III and IV are based on the same dataset. A summary of the study methods is 
provided in Table 1. 
 
Table 1. Summary of designs, participants, data collection, and statistical analyses for the studies 
included in the thesis. 
Study Design Participants Data collection Statistical analyses 
I 
 
Cross-
sectional 
 
Parents of 
children and 
adolescents with 
chronic pain 
(n=263) 
 
Self-report assessments 
(paper, first visit to 
clinic) 
 
 
Descriptive statistics, factor 
analysis (PCA), Cronbach’s 
alpha, correlation and regression 
analyses 
 
II 
 
 
Randomized 
uncontrolled 
pilot 
 
Adolescents with 
debilitating 
chronic pain 
(n=48 at pre) 
Parents 
(n=28 at pre) 
 
Semi-structured 
interviews, self-, and 
proxy-report 
assessments (paper, 
pre, mid, and post 
treatment) 
 
Mean-based statistics (Jacobson-
Truaxa), Mann Whitney U-test, 
Wilcoxon signed rank's test, 
effect size calculations 
III 
 
Cross-
sectional 
 
 
Children and 
adolescents with 
chronic pain 
(n=146) 
Parents 
(n=146) 
 
Self- and proxy-report 
assessments (paper, 
first visit to clinic) 
Descriptive statistics, 
independent t-test, Mann 
Whitney U-test, c2-test, Fisher’s 
exact test, effect size calculations 
IV 
 
Cross-
sectional 
 
Children and 
adolescents with 
chronic pain 
(n=146) 
Parents 
(n=146) 
Self- and proxy-report 
assessments (paper, 
first visit to clinic) 
 
Descriptive statistics, 
independent t-test, correlation 
and regression analyses, effect 
size calculations, analyses of 
indirect effects/mediation 
 
Note. a Method using mean-based statistics to calculate clinically significant changes; PCA, Principal Component Analysis. 
 
4.2 ETHICAL CONSIDERATIONS 
The research on which this thesis is based was conducted in accordance with the 1975 
Helsinki Declaration of Ethical Principles and subsequent revisions [175].  
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4.2.1 Ethical permits and consent 
The four studies were approved by the Regional ethical review board in Stockholm 
(Regionala etikprovningsnamnden i Stockholm, FE 289, 171 77, Stockholm, Sweden). The 
ethical permits are 2009/470-31/3, and amendment 2011/1734-32 (Study I); 2009/815-31/4 
(Study II); and 2013/231-31-4 (Study III and Study IV). Participating children, adolescents, 
and parents in the four studies were presented with age-appropriate study information in 
writing. Concerning the study information in the two studies III and IV, where children 
between the ages 8-12 years were also included, particular care was taken to explain why 
the research was conducted and the implications of participation in an easy-to-understand 
wording. All participants were required to provide written informed consent to participate 
in the research before study inclusion. In the information it was clearly stated that any study 
participation was voluntary, that study participation could be interrupted by the participant 
at any time without explanation, and that declining participation would not affect 
subsequent care in any way. In study II, for instance, patients that chose not to participate in 
the study, but were still eligible for treatment according to standard clinic requirements, 
were offered the treatment program provided within the ordinary care at the tertiary clinic. 
4.2.2 Risks and benefits 
Regarding the cross-sectional studies (Studies I, III, and IV), with no treatment 
intervention, potential violation of integrity was seen as the most serious ethical concern, 
followed by the burden of assessment, i.e. time and effort spent on completing 
questionnaires. All self-report questionnaires were coded for anonymity and stored in 
locked facilities, and files were encrypted and stored on a secure computer to minimize the 
risk of integrity violation. The included self-report instruments were thoroughly evaluated 
for relevance (validity) vis-à-vis the research questions, which has been suggested as more 
important than time spent on completion [176]. Regarding the intervention study (Study II), 
ethical concerns, besides the burden of assessment as described above, included the 
possible risks of adverse events from participating in a psychological intervention that 
could possibly entail increased levels of distress and pain. Thorough information regarding 
treatment objectives and the possibility for increased negative symptoms were therefore 
provided to participants. Adverse events were also analyzed in terms of clinically 
significant deterioration and were subsequently reported, as recommended but not always 
done according to the literature [177]. 
 
All studies in the thesis are conducted on clinical samples of children and adolescents with 
chronic pain and their parents. Pediatric chronic pain is seen as an important area of 
research, being a current major health concern that often persists into adulthood. Achieving 
a deeper understanding of the child with chronic pain, including contextual factors of 
relevance to functioning, such as neurodevelopmental comorbidity and parental coping, 
was considered important as it could pave way for better screening methods to detect 
factors that may go unnoticed, as well as novel and tailored interventions to more 
effectively address these factors. Through developing a shorter instrument, with satisfactory 
validity, the patient burden of assessment could ultimately be reduced. Specifically, 
concerning the participating children, it was assessed that increased knowledge about 
chronic pain and neurodevelopmental comorbidity eventually could lead to more effective 
care for the group as a whole, and possibly fewer unnecessary assessments. 
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psychological treatments could also constitute valuable additions and provide insight on 
overall terms of functioning in pediatric chronic pain. In terms of the participating 
parents or next-of-kin, increased knowledge about factors influencing pediatric chronic 
pain and disability, and how to address own worry, could lead to less concern (or more 
adequate concern) in parents and other relatives, potentially resulting in an improved ability 
to coach the child in pain. In the long term, informing effective treatments and better 
assessments will probably also mean less time spent in hospitals or clinics. In terms of 
healthcare, effective assessment and treatment of patients with pediatric chronic pain 
probably entails improved management of resources e.g. through fewer health care contacts 
and more satisfied patients. Finally, in terms of community, savings in terms of reduced 
school- and work absences could come as a result of improved assessment and treatment. In 
summary, it was concluded that the benefits would outweigh the risks associated with the 
research included in the current thesis. 
4.3 RESEARCH SETTING 
The samples of children and adolescents and their accompanying parents included in the 
four studies in this thesis were all recruited from a tertiary pain clinic at the Karolinska 
university hospital in Stockholm. The clinic employs pain physicians, psychologists, and 
physiotherapists and provides specialized expertise in assessment and treatment of pediatric 
chronic pain in an outpatient care setting with an interdisciplinary focus. Referrals are 
received from mainly secondary care but also from tertiary care facilities in a number of 
therapeutic areas. Healthcare in Sweden, including tertiary care, is largely tax-funded and 
all non-acute healthcare for children under the age of 18 is completely free of charge, which 
means that access to care at the tertiary pain clinic did not require a private health insurance 
or other specific fees. 
4.4 PARTICIPANTS AND PROCEDURES 
All child- and adolescent participants included in the current studies were referred to the 
tertiary pain clinic because of chronic pain. 
4.4.1 Study I 
The first study included 263 parents (213 women) of children and adolescents with chronic 
pain who were referred to the tertiary care pain clinic during a period of four consecutive 
years. At the child's first visit to the clinic, accompanying parents were invited to 
participate in the study, and participants provided data before the child's initial assessment 
through self-report questionnaires. Non-Swedish speakers were excluded from the study. 
The mean parental age was 44.4 years (SD = 6.5) and 53% of parents reported their 
education to be at university level. Child data were also collected and reported elsewhere 
[26, 178]. In brief, 72% were girls and the mean age was 14 years (SD = 2.64). The mean 
pain duration was four years and most children reported pain from multiple body sites 
(76%). 
4.4.2 Study II 
The second study initially included 48 adolescents (ages 12-18 years), with continuous 
chronic pain since more than six months not fully explained by a pathophysiological 
process, with substantial ongoing disability due to mainly pain (e.g. not a psychiatric 
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condition), and poor effects of previous treatments for pain without other on-going or 
planned treatments. Adolescents with an imminent suicide risk, severe cognitive 
dysfunction or reduced proficiency in Swedish were furthermore not eligible to participate 
in the study. The 48 eligible participants were randomized to a group (n = 24) or individual 
(n = 24) condition for treatment with an outpatient 18-session interdisciplinary ACT-based 
treatment, that included four parental sessions, of which one was a joint adolescent-parent 
session. The accompanying parents were offered to participate in the parent program with 
the same treatment condition (group or individual) as their adolescent. However, only one 
parent per adolescent was asked to provide data for the study. Data collection on pain- and 
demographic variables, in order to determine eligibility for participation in the study, was 
performed at the initial assessment at the clinic through a semi-structured clinical interview. 
Data on child- and parent outcome measures was collected by means of self-report 
assessments at three time points: pre-, mid-, and post-treatment. Following attrition and a 
change in age criteria to 14-18 years, the final sample consisted of 30 adolescents (24 girls) 
with a mean age of 16 years (SD = 1.6), and 28 parents (24 women) with a mean age of 
47.3 years (SD = 4.8). Of parents, 57.7 % reported having chronic pain themselves. Six 
parents were subsequently excluded because data was not provided by the same parent at 
all time points, leaving 30 adolescents (12 in group- and 18 in individual condition) and 22 
parents (11 in group- and 11 in individual condition) to be included in the analysis.  
4.4.2.1 The parental intervention 
Within the 18-session treatment program, the four parental sessions were number 3, 6, 11, 
and 12 (joint session), and they were thus intertwined with the 15 adolescent sessions 
(including the joint session). Parental home assignments were also given at one point 
(session 6). The purpose of the parent program was to enhance the ability of parents to 
support increased functioning in their adolescent through pain education, contingency 
management, including clarification of own values (conceptualized as long-term 
reinforcers), and the use of acceptance-skills to manage own distress due to their child's 
pain. 
4.4.3 Study III and Study IV 
The third and fourth studies were conducted on the same set of participants and included 
146 children and adolescents with chronic pain (102 girls) with a mean age of 14.55 years 
(SD = 2.40), and their parents (one parent per child; 111 women) with a mean age of 45.67 
years (SD = 5.74). Own chronic pain conditions were reported by 32.8 % of parents. Of 
children, 93.8% reported pain since longer than 6 months and 69.2% experienced daily pain 
episodes, with an additional 24% experiencing pain several times a week. Multiple pain 
sites were reported by 74% of children with an average pain intensity for the primary pain 
of 59.02 (max 100, SD = 13.55). Furthermore, 61.7% of children reported not knowing 
(including not having received) any diagnosis for their pain, and 35.4% reported not 
knowing any reason for initial pain onset. Participants were consecutively referred to the 
tertiary pain clinic during a period of three years.  
 
The parent-child dyads were invited to participate in the studies before the child’s initial 
assessment at the clinic, and consenting individuals provided data through two individual 
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sets (parent and child) of self-report questionnaires that were returned in person before the 
first clinical assessment. Non-Swedish speakers were excluded, as were implicitly also 
children who were unable to answer the questionnaires by themselves.  
4.5 ASSESSMENTS 
4.5.1 Overview of instruments and assessed variables 
As noted in Table 1, the results from the studies within this thesis were mainly based on 
self-reports from both children and their accompanying parents. An overview of the self-
report instruments used and the assessed variables is provided in Table 2. 
 
Table 2. Instruments and assessed variables for each study included in the thesis by type of 
participant (child/parent) and excluding demographics and other background variables. 
Study Child instruments Child assessed variables 
Parent 
instruments 
 
Parent assessed variables 
 
I N/A N/A HADS, PPFQ 
 
Parental distress (anxiety 
and depression), parental 
psychological flexibility in 
the context of child's pain 
 
II 
NRS 0-6, PIPS, 
PII, PRS, CES-
DC 
 
Pain intensity, 
psychological inflexibility 
in context of pain, influence 
of pain on 
functioning/behaviors, 
worry/emotional reactivity 
to pain, depressive 
symptoms 
 
HADS, PPFQ, 
PRS-P,  
FDI-Pa 
Parental distress (anxiety 
and depression), parental 
psychological flexibility in 
the context of child's pain, 
parental emotional 
reactivity to child's pain, 
child functioning 
II LPQ 
 
Pain variables: Pain 
duration, pain frequency, 
pain site/s, perceived 
trigger/s of pain, perceived 
reason/s for first pain onset, 
pain diagnoses, co-
occurrence of other chronic 
disease 
 
SRS,  
Conners 3 
Autistic traits in child, 
ADHD-symptoms in child 
IV 
LPQ, CES-DC, 
PII, PedsQL, 
ISI, PIPS 
 
Pain variables (as above), 
depressive symptoms, 
influence of pain on 
functioning/behaviors, 
HRQoL, insomnia, 
psychological inflexibility 
in context of pain 
SRS,  
Conners 3 
Autistic traits in child, 
ADHD-symptoms in child 
Note. a Child outcome; N/A, not applicable; HADS, The Hospital Anxiety and Depression Scale; PPFQ, The Parent Psychological 
Flexibility Questionnaire; NRS, Numerical Rating Scale; ISI, Insomnia Severity Index; PIPS, Psychological Inflexibility in Pain Scale; 
PII, Pain Interference Index; PRS, Pain Reactivity Scale; PRS-P, Pain Reactivity Scale-Parents; FDI-P, Functional Disability Inventory-
Parent; CES-DC, Center for Epidemiological Studies Depression Scale; LPQ, Lübeck Pain Questionnaire; SRS, Social Responsiveness 
Scale; HRQoL, Health-related quality of life; PedsQL, Pediatric Quality of Life Inventory. 
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4.5.2 Study I 
4.5.2.1 Demographic- and variables for adjustment/control (self-report) 
Parental background information and demographics were assessed by means of self-report 
and included parental age (years), gender, and educational status (basic education/high 
school or university studies).  
4.5.2.2 Factor structure and internal consistency (self-report) 
The instrument subject to validation, the Parental Psychological Flexibility Questionnaire 
(PPFQ) [130, 131], was used in a version containing the 17 items and four subscales/factor 
structure: VBA (values-based action); EA (emotional acceptance); (pain acceptance); and 
PW (pain willingness), as proposed by Wallace et al. [130]. The PPFQ measures parental 
psychological flexibility within the context of the child’s pain, and is defined as the parent’s 
willingness to experience distress related to the child’s pain in the service of long-term 
values and related behavioral goals for both parent and child [179]. The PPFQ was 
translated from English to Swedish based on standards for self-report translation and cross-
cultural adaption [180]. 
4.5.2.3 Relationship with distress: PPFQ-concurrent criterion validation (self-report) 
Parental distress (anxiety and depression) was assessed using the Hospital Anxiety and 
Depression Scale (HADS) [181, 182]. The HADS includes two subscales measuring the 
respective aspects of distress: anxiety (HADS-a) and depression (HADS-d). 
4.5.3 Study II 
4.5.3.1 Demographic-, background-, and screening variables (self- and proxy-report, 
semi-structured interview) 
Semi-structured screening interviews were used to collect information concerning 
adolescent demographic-, school, and pain characteristics (pain frequency and duration, 
pain location, and pain medication). Parental background information and demographics 
were assessed by means of self-report and included age, gender, educational- and work 
status, marital status, and own chronic pain conditions.  
4.5.3.2 Adolescent outcome measures (self- and proxy reports) 
Six variables were assessed as child outcomes. A numerical rating scale was used to assess 
pain intensity on a scale from 0 (no pain at all) to 6 (extreme pain). The Pain Interference 
Index (PII) was used to assess the impact of pain on everyday functioning/behaviors [26]. 
Emotional reactivity to pain and worry was assessed with the Pain Reactivity Scale (PRS) 
[10]. The Center for Epidemiological Studies Depression Scale Children (CES-DC) was 
used to assess depressive symptoms [183]. Psychological inflexibility in the chronic pain 
context, defined as an inability to pursue valued behaviors in the presence of pain and 
distress, was evaluated using the Psychological Inflexibility in Pain Scale (PIPS) [106]. 
Finally, The Functional Disability Index (FDI) [184] in a parent version, and completed by 
parents, was used to assess adolescent functioning. 
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4.5.3.3 Parent outcome measures (self-reports) 
Three variables were assessed as parent outcomes. Parental distress (anxiety and 
depression) was assessed using the Hospital Anxiety and Depression Scale (HADS) [181, 
182]. For the assessment of parental emotional reactivity to the child’s pain, the Pain 
Reactivity Scale was used in a parent version (PRS-P). Finally, for the assessment of 
parental psychological flexibility within the context of the child’s pain, the Parent 
Psychological Flexibility Questionnaire (PPFQ) was used in the 10-item version developed 
through the psychometric evaluation and factor analysis performed in Study I [185]. 
4.5.4 Study III 
4.5.4.1 Demographic- and background information (self- and proxy-reports) 
Parental background information and demographics were assessed through self-report and 
included parental age (years), gender, health, rated from 1 (poor) to 5 (excellent), parental 
chronic pain (yes/no), and educational status (basic education/high school or university 
studies). Child demographic and background variables were also collected by means of 
(child) self-report and included gender, age (years, months), and chronic disease other than 
pain, and parents provided information on confirmed diagnoses of ADHD and/or ASD in 
their children. 
4.5.4.2 Pain characteristics (child self-report) 
The Lübeck Pain Questionnaire (LPQ) [20, 108] was used to assess pain characteristics in 
children. The LPQ is a structured self-report questionnaire containing predefined single-
item, and multi-item scales (yes/no) evaluating pain duration and pain frequency during the 
preceding 3 months, pain site/s, perceived trigger/s of pain, and perceived reason/s for first 
pain onset. 
4.5.4.3 Symptoms and traits of ASD and ADHD (parent proxy-reports) 
For the assessment of autistic traits in children, parents completed the Swedish version of 
the parent report form of the Social Responsiveness Scale (SRS), and the original American 
norms were used for comparison [186, 187]. Clinically significant ASD-traits have been 
associated with T-scores ≥60, and T-scores ≥75 are associated with an ASD diagnosis in 
the severe range [188]. Established cutoffs reliably distinguish children with ASD from 
non-affected children and children with other child psychiatric conditions [186]. In order to 
assess symptoms of ADHD in children, the Swedish version of the Conners 3 parent report 
form was used, along with Swedish norms [189, 190]. The Conners 3 generates an ADHD 
Index that accurately differentiates children with ADHD from children without a clinical 
diagnosis [191]. T-scores ≥60 indicate an elevated score and T-scores ≥65 are associated 
with clinically significant ADHD symptoms. 
4.5.5 Study IV 
4.5.5.1 Variables for adjustment/control (child self-report) 
Child demographic- and pain variables were collected as in Study III. In Study IV, 
however, only data concerning gender and age was used and assessed as control/adjustment 
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variables along with pain intensity from the LPQ. In the LPQ pain intensity was assessed 
with a visual analog scale (VAS; 0-100 mm, six faces from laughter to crying) following 
the question: “How intense is your main pain usually?”. 
4.5.5.2 Dependent variables (child self-report) 
Three variables related to child functioning and HRQoL were assessed as dependent 
variables. The PII was used to assess the impact of pain on everyday functioning/behaviors, 
and the CES-DC was used to assess depressive symptoms. HRQoL was assessed using the 
Pediatric Quality of Life Inventory 4.0 core scales (PedsQL) [192]. The PedsQL has been 
used in several studies, in healthy children, in children with chronic conditions [101, 193-
195], and in children with chronic pain [101, 196, 197].   
4.5.5.3 Predictor variables (parent proxy-reports) 
Two variables assessing traits and symptoms of neurodevelopmental disorders in children 
were used as the predictor variables. ASD-traits were assessed and collected as in Study III 
using the SRS and data on ADHD-symptoms were likewise assessed and collected using 
the Conners 3.  
4.5.5.4 Variables for analyses of indirect effects/mediators (child self-reports) 
Two variables, insomnia and psychological inflexibility in the context of pain, were 
analyzed for indirect effects on the relationships between predictor- and dependent 
variables. Insomnia (perceived sleep difficulties) was assessed using the Insomnia Severity 
Index (ISI) [178, 198]. Relating to the past two weeks, ISI evaluates sleep patterns, 
satisfaction with the current sleep pattern, problems with daily functioning due to insomnia, 
sleep worry, and noticeability by others. Psychological inflexibility in the chronic pain 
context was evaluated using PIPS. 
4.5.6 Benefits and limitations of self-report 
The specific limitations concerning the use of self-report assessments pertaining to the 
studies in this thesis are addressed in the limitations section below (6.6). In a general 
context, self-report data has been suggested as essential to behavioral and clinical research, 
as well as to medical practice, as a valuable and unique source of information that should 
not be seen as a mere substitute for other methods of verification [199]. However, caution 
regarding self-report should also be taken. In one study on pediatric chronic pain patients, 
results e.g. suggested that higher scores for self-reported social desirability were associated 
with lower scores for self-reported psychological distress, interpreted as indicative of social 
desirability response bias [200]. Overall, however, research that span a number of fields 
and study designs, including pediatric chronic pain [14, 201], cognition, psychometric-, and 
longitudinal studies, point to the value of self-report instruments and that children, from the 
age of 6 years and with certainty from the age of 8 years, can reliably complete age-
appropriate self-report questionnaires and supply valuable information concerning their 
own health-status, with a predictive value [202]. In terms of assessing behavioral 
dimensions and medical history, parent proxy-reports also constitute an important 
contribution [22]. In summary, self-report can be a valuable and unique source of 
information but the use of self-report, like any method of measurement, should include a 
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thorough assessment of aspects related to instrument validity and reliability, research 
setting, the type of respondent (age, cognition) [203], response bias, and ethical concerns 
[199]. 
4.6 STATISTICAL ANALYSES 
All analyses in the studies included in this thesis were performed using SPSS in version 22 
(Study I), version 23 (Study II), and version 25 (Studies III and IV) [204]. Analyses of 
indirect effects (Study IV) were performed using PROCESS for SPSS [205]. In every 
study, descriptive statistics were used to examine the data, including checking for missing 
values and ascertaining valuable distributions. Missing data were in all samples found to be 
missing completely at random (Little’s MCAR =ns.) [206]. The percentages of missing data 
points for included participants per variable are reported in detail in each article, but overall 
missing data points were below 1% across all data sets. Imputation of missing data was 
largely handled using the expectation maximization algorithm (EM) [207] (Study I, III, and 
IV), and in Study II trough person mean imputation. The choice of statistical analyses was 
made based on the research question at hand, the type of variable (numerical, categorical), 
the number of groups studied, and variable distributions (normal, non-normal) [208]. Table 
3 provides an overview of the statistical analyses used in relation to each study and research 
question. 
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Table 3. Overview of the statistical analyses used in the four studies in the thesis by study and 
research question. 
Study Research questions Statistical Analyses 
I Exploration of PPFQ-factor structure and loadings Principal Component Analysis (PCA) 
I Determination of PPFQ-internal consistency and item contribution Cronbach’s alpha 
I Assessment of PPFQ-concurrent criterion validity: strength (and function) of relationship with HADS 
Correlation and hierarchical 
multiple regression analyses 
II Assessment of differences in measures between groups: treatment format (group/individual) 
Mann–Whitney U-tests (non-
normal)   
II Assessment of temporal changes in outcomes following ACT-intervention (pre, mid, post) 
Wilcoxon signed-rank tests 
(non-normal) 
II Assessment of clinically significant changes in outcomes following ACT-intervention 
Mean-based statistics 
(Jacobson–Truax method) 
III Assessment of prevalence/occurrence of clinically significant traits/symptoms of ASD/ADHD 
Descriptive statistics (T-score 
means, SD, percentages) 
III, IV 
Assessment of differences between groups (group status: 
clinically significant traits/symptoms of ASD/ADHD) for 
numerical variables 
Independent t-tests (normal), 
Mann–Whitney U-tests (non-
normal) 
III 
Assessment of equality of proportions by group status 
(clinically significant traits/symptoms of ASD/ADHD) for 
categorical variables (yes/no) 
c2-tests, Fisher’s exact tests 
II, III, IV Analysis of effect sizes r, Cohen's d, Hedge's g 
IV Examination of variable relationships: strength  Correlation analyses 
IV Examination of variable relationships: function/predictive value 
Hierarchical multiple 
regression analyses 
IV Analysis of indirect effects (mediation) Bootstrapping (resampling) 
Note. PPFQ, The Parent Psychological Flexibility Questionnaire; HADS, The Hospital Anxiety and Depression Scale; ACT, Acceptance 
and Commitment Therapy; ASD, Autism spectrum disorder; ADHD, Attention-deficit hyperactivity disorder; SD, Standard deviation. 
 
Throughout the studies, a correlation of r = ±.00 - .29 was considered weak, r = ±.30 -.49, 
moderate, r = ±.50 - .89, strong, and, r ≥ ± .90, very strong [209]. Effects sizes (Study II, 
III, and IV) were considered small (d = 0.3; g = 0.3; r = > 0.10), medium (d = 0.5; g = 0.5; r 
= > 0.30) and large (d = 0.8; g= 0.8; r = > 0.50) [210, 211]. In Study IV, clinically 
significant change was defined according to the Jacobson and Truax method [212], as a 
change from the mean of the study population of two standard deviations (SD) in the 
direction of better or worse functioning. P-value in Study I, III, and IV was set at p < .05, 
and in Study IV at p < .01.  
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5 RESULTS 
5.1 STUDY I 
The assumptions for using a PCA were met. The exploratory factor analysis of the PPFQ 
containing 17 items (PPFQ-17) and four subscales with PCA supported a three-factor 
solution with eigenvalues >1 (6.68, 2.23, and 1.38). The sequential elimination of items due 
to significant loadings on several factors, poorer extraction within the factor structure, or 
negative contributions to overall scale reliability (alpha) resulted in a final PPFQ-version of 
10 items (PPFQ-10) and three factors that explained 69.5% of the item-variance. The three 
factors matched the factor/subscale labels: values-based action (VBA), pain willingness 
(PW), and emotional acceptance (EA) proposed by the authors of the original PPFQ in 
Wallace et al. [130], and were retained (Table 4). One of the original subscales/factors, pain 
acceptance (PA), was eliminated in the process of item reduction. Full scale internal 
consistency was good (α = 0.86) and for subscales fair (PW, α = .73), moderate (VBA α = 
.76) and excellent (EA α = .87), accounting for the number of items [213], and satisfactory 
levels of skewness and kurtosis for a normal distribution were observed.  
 
Table 4. Factor loadings and communalities based on a principle components analysis with oblimin rotation 
for 10 items from the 17-item version of the PPFQ (n = 263). 
Item No.a Itema 
Factor loadings (PCA)b 
Emotional 
Acceptance 
(EA) 
Pain 
Willingness 
(PW) 
Values 
Based 
Action 
(VBA) 
Communality 
(extraction) 
7 Despite my child’s pain, we are able to pursue activities that are important to our family  .157 .820 .721 
8 
When my child has pain episodes I am able to 
remain aware of our goals and other things 
that are important to us as a family. 
.271 -.113 .715 .696 
11 It is possible to live a normal life while my child suffers with pain.   .814 .652 
9r I avoid situations where my child will have pain.  .756 .124 .607 
13r Pain control must come first whenever my child does activities.   .780 -.138 .698 
24r My child must avoid activities that lead to pain.   .826  .683 
22r I suffer terribly from my child’s pain and need to make this suffering stop. .830   .744 
26r My child’s pain makes it impossible to focus on anything else. .683  .243 .717 
28r I am overwhelmed by worry over my child’s pain. .845   .753 
31r I struggle with my own thoughts and feelings about my child’s pain.  .853   .681 
Note. aFrom the original PPFQ by McCracken et al.; r = reversed scored item. Values are reported from the pattern matrix, sorted by 
subscale; total variance explained = 69.5%; Factor loadings < 0.1 are suppressed; b Extraction method: PCA, with oblimin as the rotation 
method (kaiser normalized; rotation converged in five iterations); EA, emotional acceptance; PW, pain willingness; VBA, values-based 
action. 
 
In total, 35% and 21% of parents scored at or above the clinical cutoff of 8 for anxiety 
(HADS-a) and depression (HADS-d) respectively [182]. Psychological flexibility (PPFQ-
10) had a strong and negative relationship with anxiety (p < .001), and with depression (p < 
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.001). Lower psychological flexibility was associated with higher distress. The PPFQ-10 
further significantly contributed to the prediction of anxiety (p < .001) and depression (p < 
.001), and accounted for 29% of the variation in HADS-a and for 35.6% of the variation in 
HADS-d, with adjustment for age, gender, and education. 
5.2 STUDY II 
Comparing the results on pre-treatment assessments between the adolescents (n=30) and 
parents (n=22) that completed the study, and those who were excluded or dropped out, no 
significant differences were found.  
 
No significant differences were found between treatment conditions (group and individual), 
using the statistical significance level of p < .01. Significant improvements (p = .001 and p 
= .004) post-treatment, with medium to large effects, were seen among adolescents for pain 
reactivity (PRS), psychological inflexibility (PIPS), pain interference (PII), and depression 
(CES-DC). Parent FDI-ratings of functional disability concerning their adolescents did not 
show a significant improvement (p = .032). Significant improvements in adolescent 
variables were mainly seen from pre- to post, and from mid- to post treatment. 
 
Concerning parental variables, parents reported a pre-treatment median anxiety score of 9 
on the HADS-a, and a pre-treatment median depression score of 5.5 on the HADS-d. In 
terms of parental outcomes, significant (p = .001) improvements post treatment, with large 
effects, were seen in parent pain reactivity (PRS-P), and parent psychological flexibility 
(PPFQ). Significant improvements in these variables were seen from pre- to post, and from 
mid- to post treatment. Of parents, 76% (PRS-P) and 54% (PPFQ) also showed clinically 
significant improvements. Changes in parent anxiety or depression were not significant. 
5.3 STUDY III 
Of all children, 20 (13.7% in total; 17.6% of girls; 4.5% of boys) received scores equivalent 
to clinically significant ASD (SRS) and 29 children (19.9% in total; 19.6% of girls; 20.5% 
of boys) received scores equivalent to clinically significant ADHD (Conners 3). In 
combination, the total sample prevalence of clinically significant ASD-traits and ADHD-
symptoms was 26% (38 children, including 11 children receiving scores above clinical 
cutoff on both instruments). Of all children, 4.8% of had an indicated previous diagnose of 
either ADHD, ASD or both (one child; 0.7% in total). 
 
Concerning demographic- and background variables, girls were more likely to have 
clinically significant ASD-traits (p =.035), and parents of children with scores below the 
cutoff for clinically significant ASD-traits reported significantly better health than parents 
of children above cutoff (p =.020). Also, parents of children with clinically significant 
ADHD-symptoms were less likely to report a university education (p =.034). No other 
significant differences regarding demographic or background variables were found.  
 
In terms of pain characteristics, results for pain duration, pain frequency, or pain sites did 
not show any significant differences between children with and without clinically 
significant ASD-traits or ADHD-symptoms. Concerning pain triggers, in children with 
clinically significant ASD-traits, pain was more likely triggered by being in school (p 
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=.007), while pain in children with clinically significant ADHD-symptoms was more likely 
triggered by “New situations” (p =.006) and by the “Family situation” (p =.008). Finally, 
children with clinically significant ASD-traits were more likely to not know of any reason 
for initial pain onset (p =.003). 
5.4 STUDY IV 
Of all children, 58% reported a HRQoL (full PedsQL scale) below or equal to at-risk (for 
poor HRQoL) [194, 214]. Also, 35% reported significant depressive symptoms (CES-DC) 
[183] and 43% reported clinically significant insomnia (ISI) [215].  
 
Children above cutoff for clinically significant ASD-traits (SRS) and ADHD-symptoms 
(Conners 3) (combined; n = 38) reported significantly lower HRQoL than children (n = 
108) below cutoff (p < .001) on the PedsQL full scale and all four subscales, with large 
effects for emotional-, social-, and school functioning. Children above cutoff also reported 
significantly (p < .001) higher levels of pain interference (PII), and significantly (p < .001) 
more depressive symptoms than children below cutoff. These effects were large.  
 
With reference to at-risk cutoff scores for the PedsQL and CES-DC, 79% of children above 
cutoff for clinically significant ASD/ADHD-traits and symptoms reported a HRQoL equal 
to or below at-risk (children below ASD/ADHD cutoff, 50%), 58% reported significant 
depressive symptoms (children below ASD/ADHD cutoff, 28%), and 63% reported 
clinically significant insomnia (children below ASD/ADHD cutoff, 36%). 
 
Both higher levels of ASD-traits, and higher levels of ADHD-symptoms were, to a 
moderate degree, associated with higher levels of depressive symptoms and pain 
interference respectively (p < .001), and with lower levels of HRQoL (p <.001). ADHD-
symptoms and ASD-traits further contributed significantly to the prediction of HRQoL (p < 
.001), depressive symptoms (p < .001), and pain interference (p < .001), and in combination 
accounted for 14.3% of the variation in PedsQL, 15.2% of the variation in CES-DC, and 
11.3% of the variation in PII, with adjustment for age, gender, and pain intensity. In terms 
of their individual contributions, both C3 and SRS obtained significant beta coefficients for 
all dependent variables, with the largest unstandardized beta coefficients for HRQoL. 
 
Analyses of indirect effects showed significant (p ≤ .01) indirect effects of insomnia (ISI) in 
each of the relationships between ADHD-symptoms and the dependent variables 
(depressive symptoms, pain interference, and HRQoL), with adjustment for the covariates 
age, gender, and pain intensity. In contrast, no significant indirect effects were seen for 
insomnia in any of the relationships between ASD-traits and the dependent variables. In 
similar analyses of indirect effects, significant (p ≤ .01) indirect effects of psychological 
inflexibility (PIPS) in all of the respective relationships between ADHD-symptoms and 
ASD-traits and the dependent variables were found. In three models (Conners 3 - PII; SRS - 
PII; SRS - PedsQL) with PIPS as the mediator, the direct effects (c´) between the predictor 
and the dependent variables were non-significant, indicating a strong mediating effect of 
psychological inflexibility on these relationships. 
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6 DISCUSSION 
 
The purpose of this research project was to identify and assess parental and child factors of 
importance for functioning and treatment effects in pediatric chronic pain. More 
specifically, the project aims were to validate an instrument for parental psychological 
flexibility (Study I), to assess the effects of a brief parental ACT-intervention on parent 
outcomes (Study II), to assess the prevalence of traits and symptoms of ASD and ADHD 
in children (Study III), and to explore the relationships between traits and symptoms of 
ASD and ADHD, functioning, and HRQoL (Study IV). 
6.1 MAIN FINDINGS 
In Study I, the construct validity and reliability of the Swedish translation of the PPFQ was 
confirmed. Also, the psychometric analyses resulted in a shortened instrument with a total 
of 10 items and three (instead of four) [130] factors (i.e. PPFQ-10). PPFQ-10 explained a 
significant amount of variance in both criteria variables, i.e. parental anxiety and 
depression. In Study II, parents of adolescents with chronic pain showed significant 
improvements in psychological flexibility and pain reactivity following a brief ACT-based 
parental intervention, with clinically significant increases in functioning for a majority of 
parents. Study III showed that the total prevalence of clinically significant ASD-traits and 
ADHD-symptoms in this sample of children presenting with chronic pain in tertiary care 
was 26% (ASD-traits13.7%; ADHD-symptoms 19.9%). Clinically significant ASD-traits 
were more prevalent in girls than boys, but no gender differences were seen in clinically 
significant ADHD-symptoms. In Study IV, ASD-traits and ADHD-symptoms significantly 
predicted pain interference and depression, as well as reduced HRQoL in children with 
chronic pain. Children with clinically significant ASD-traits or ADHD-symptoms had 
significantly higher levels of depressive symptoms and pain interference, and significantly 
lower HRQoL, compared to the rest of the sample. When exploring the nature of these 
relationships, psychological inflexibility was shown mediate the influence of ADHD-
symptoms as well as ASD-traits on the dependent variables (depression, pain interference, 
and HRQoL). Also, insomnia mediated the relation between ADHD-symptoms and 
dependent variables.  
6.2 CHILD CHARACTERISTICS 
The samples of children included in this research project were comparable on demographic 
variables and clinical correlates, such as pain, depression, and insomnia, to existing studies 
on pediatric chronic pain. The samples e.g. included a large majority of girls, having a 
mean pain duration exceeding six months, and daily pain episodes when presenting for 
tertiary care [18, 21, 23, 26, 27]. In all three samples, a majority of children (56 - 76%) also 
reported pain from multiple body sites, which concurs with research showing that many 
children with chronic pain report multi-site pain [24, 25], particularly girls [24]. Also, 
children in the included samples (Study II, III and IV) reported headache and abdominal 
pain as the most common pain sites, which is consistent with existing studies [18, 24], 
which have also shown a higher risk of experiencing pain from additional locations when 
presenting with headache or abdominal pain [24]. A considerable number of children in the 
included samples further presented with clinically significant levels of depressive 
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symptoms (Study II, III and IV), i.e. at or above 24 on the CES-DC [183]. In Study IV, 
58% of children reported a level of HRQoL that was below or equal to the cut-off for poor 
HRQoL [194, 214]. Furthermore, 43% reported clinically significant insomnia (ISI) [215]. 
These results are also in line with other studies on pediatric chronic pain showing that sleep 
disorders [75] and comorbid mental health conditions [8, 52] are common, and that children 
with chronic pain report significantly lower HRQoL than children with other chronic 
conditions and healthy children [101]. In summary, the typical child with chronic pain 
included in the current project was a teenage girl experiencing multi-site pain, mainly from 
the head and stomach, with comorbid depressive symptoms, insomnia, and poor HRQoL, 
and results provide additional support for the relationships between pediatric chronic pain, 
insomnia, and poor HRQoL [74, 75, 99, 101, 178, 214, 216]. 
6.3 PARENTAL FACTORS 
Of the accompanying parents in the current studies, a majority were mothers and 33 - 58% 
reported having own pain conditions. Chronic pain conditions have been found to be 
common among parents of children with chronic pain [47], and parental own chronic pain 
has, as noted earlier, been associated with an increased risk for anxiety and depression in 
children [48] as well as poorer outcomes than for other children with non-afflicted parents 
[49]. Notably, the level of own pain in parents was considerably higher in Study II (58%), 
that only included adolescents with debilitating chronic pain, than in Studies III and IV 
(33% own pain). The mean and median parental anxiety and depression scores on the 
HADS in Study I and II were also at or above the clinical cutoffs [182, 217], with 
particularly elevated scores for anxiety among parents in Study II. Anxiety is frequently 
reported among parents of children with chronic pain along with depressive symptoms 
[218], and has been shown to predict child depression and functioning in longitudinal 
studies [46]. Overall, parental sample characteristics and clinical correlates are consistent 
with previous research in pediatric chronic pain and emphasize the relationships between 
parent and child clinical profiles in pediatric chronic pain [42].  
 
The construct of parental psychological flexibility was shown to display consistency also in 
a Swedish sample of parents in Study I. This points to the instrument's clinical utility in 
assessment of parental flexibility in handling distressing situations vis-à-vis their child’s 
pain. The strong associations between PPFQ and parental anxiety and depression may 
indicate that lower psychological flexibility, as an indication of behavioral rigidity/rule 
governed behavior, potentially increases the risk for less adaptive and avoidance driven 
behavior, which may eventually lead to a feeling of helplessness and distress. Studies on 
parent's distress in pediatric chronic confirms this pattern between behavior and distress, 
including feelings of helplessness and child age-inappropriate parenting [42]. 
  
The inclusion of parents in the treatment of pediatric chronic pain is encouraged but 
significant treatment effects have typically been lacking, particularly in the long term [118]. 
Recent studies, however, show that parental distress over time predicts child disability, 
stressing the importance of parental factors. [119, 120]. In Study II the parental levels of 
psychological flexibility and pain reactivity were significantly improved, while levels of 
parental distress were not. This corresponds well with the conceptualization provided by 
learning theory and RFT [121]. Notably, psychological flexibility may result in more 
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activity engagement and thus more exposure to distress [121], which further implies the 
relevance of analyzing the temporal aspect of changes in the proposed mechanisms 
(psychological flexibility) and outcome variables. In summary, effects from studies on 
parental interventions in pediatric chronic pain are emerging, and the results from Study II 
provides tentative additional support for the involvement of parents. A majority of parents 
reported improvements that were also clinically significant with regard to managing the 
pain of their child. This indicates that psychological flexibility may constitute an important 
treatment target in order to increase effective parenting and improve resilience to parental 
distress. 
6.4 NEURODEVELOPMENTAL COMORBIDITY (ASD-TRAITS AND ADHD-
SYMPTOMS) 
In Study III the prevalence of clinically significant ASD-traits was 13.7% and of clinically 
significant ADHD-symptoms, 19.9%. These numbers are clearly elevated as compared to a 
large, population-based longitudinal case-control study (SRS) [219], and in terms of mean 
T-scores, in comparison to overall instrument norms (Conners 3) [189, 220]. Using 
tentative comparisons between the results from the present study and the normal prevalence 
of ASD and ADHD, the levels of traits and symptoms indicative of neurodevelopmental 
disorders are also substantially higher [134, 135, 138], especially in girls that were found to 
show more clinically significant ASD-traits than boys. Research shows that both girls with 
ASD [221] and girls with ADHD [222] tend to be missed or disregarded in clinical practice 
and, although tentative, these findings may indicate that children with chronic pain are at 
risk for presenting with a comorbid neurodevelopmental disorder. Moreover, of all 
children, only 4.8% had a previously indicated diagnosis of ASD or ADHD, which may 
further indicate that neurodevelopmental disorders could go unrecognized in many children 
with chronic pain [163]. The lack of differences in pain variables (intensity, duration, 
frequency, and site) is interesting, and one reason may be that the current study did not 
include children with more severe neurodevelopmental deficits (e.g. to allow for self-report 
questionnaires). Thus, it is possible that children with clinically significant ASD-traits or 
ADHD-symptoms in the current study represent a subsample within the ASD- or ADHD 
spectrum with a comparatively higher level of functioning in this domain.  
  
The children with chronic pain and clinically significant traits of ASD or ADHD symptoms 
reported significantly higher levels of depressive symptoms and insomnia, more pain 
interference, and significantly lower HRQoL, than did the other children in the sample in 
Study IV. The causal direction of these relationships cannot be inferred. Tentatively, 
however, it is possible that deficits in executive function associated with ASD and ADHD 
[153], may cause difficulties in social and academic situations, which may thus function as 
a chronic stressor for these children [167]. This in turn may elevate the risk for various 
health problems [167], which is supported by research showing that medical comorbidities 
are common in ASD and ADHD [163, 164]. Research has also indicated shared 
neuropathophysiological processes between chronic pain and neurodevelopmental 
disorders. For example, hypodopaminergic state (low dopamine function) and sensory 
abnormalities have been documented in chronic pain conditions [86, 96, 98] as well as in 
ASD and ADHD [146, 223, 224], and may be linked to reward-driven behavior [98]. Also, 
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it has been suggested that children with ASD and high levels of anxiety and sensory over-
responsivity may be at risk for developing chronic pain [146]. 
  
The mediating role of insomnia on the relationships between ADHD-symptoms and 
HRQoL, depression, and pain interference is interesting in the light of recent research 
suggesting a very close connection between ADHD and sleep disturbances, which may 
contribute to some of the core ADHD symptoms [225]. Insomnia has also recently been 
suggested as a mediator in the relationships between PTSD-symptoms and pain interference 
in pediatric chronic pain [79], indicating the importance of addressing insomnia in pediatric 
chronic pain treatment. The mediating role of psychological inflexibility in the relationships 
between both ASD-traits and ADHD-symptoms and HRQoL, depression, and pain 
interference is particularly interesting because of the potential implications of psychological 
flexibility for e.g. goal orientation and resilience [123]. Maintaining focus on values and 
goals in the face of interfering stimuli may require attention and capacity for complex 
decision-making under stress. These behaviors appear closely associated with aspects of 
executive function [226], and impairments in executive function constitute central deficits 
in ADHD and ASD [153].  
6.5 CLINICAL IMPLICATIONS 
Although tentative, the results support the utility of assessing and targeting parental 
psychological flexibility in the treatment of children with chronic pain. Results further 
suggest that neurodevelopmental disorders should be assessed more frequently in children 
and adolescents presenting at pain clinics due to chronic pain. Screening is not equivalent to 
the extensive assessment required for diagnosis. However, the present research project 
shows that a relatively brief screening process facilitated detection of potentially critical 
factors in a group of children with severe impairments in a number of domains, Thus, 
screening for ASD and ADHD in pediatric chronic pain may help to identify at-risk groups. 
The mediating roles of insomnia and psychological inflexibility further suggest that 
insomnia and psychological flexibility may be potential treatment targets for children with 
comorbid chronic pain and clinically significant traits of neurodevelopmental disorders, 
particularly when these factors are high and related to functioning and HRQoL. Clinical 
interventions for these patients may further benefit from complementary strategies to 
improve attentional control skills, given how attention is both linked to executive function 
and psychological flexibility.  
6.6 LIMITATIONS  
The studies included in this thesis have a number of limitations of which some are inherent 
to their design. First, the cross-sectional design in Study I, III, and IV does not allow for 
causal or temporal inferences [227], which means that any discussions concerning possible 
reasons for results are to be regarded as merely tentative. Second, the sole use of self-
assessments for the children in Study IV may have increased the risk of common method 
bias, which potentially influences the likelihood of finding significant relationships among 
included variables. For all studies, the inclusion of objective measures of functioning, e.g. 
psychiatric diagnoses in parents (Study I and II), and e.g. school absence in children 
(Study II and IV) could have increased the validity of the findings. Third, using only 
HADS as the criteria variable in the validation of the PPFQ in Study I represents a 
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limitation, as it may not be generalizable to other criteria variables. Fourth, in Study II, the 
lack of a robust design with e.g. randomization to waitlist condition limits the internal 
validity of the results. Also, the sample of parents was relatively small, and the design did 
not allow for examination of change processes. Furthermore, follow-up assessments were 
not included, which prevents analyses of the long-term stability of treatment effects. 
Finally, although Study III was adequately powered for assessing the main research 
questions, a lager sample size would have benefitted sub-group analyses of e.g. pain sites 
and triggers further. 
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7 CONCLUSIONS AND FUTURE DIRECTIONS 
 
The present research project contributes to the field by providing more knowledge about the 
assessment and possible utility of addressing parental psychological flexibility in pediatric 
chronic pain treatment, however, more research is warranted. Future studies should e.g. 
evaluate the predictive utility of the PPFQ for child treatment outcomes, and evaluate if 
parental support programs increasing parental psychological flexibility also have positive 
effects on the children. The research also contributes with increased knowledge about 
comorbid ADHD-symptoms and ASD-traits in pediatric chronic pain, and illustrate 
significant relationships between such traits and symptoms and overall functioning in 
children. Children with debilitating chronic pain, and in particular girls, may be at risk for 
having a comorbid, and possibly undetected high-functioning neurodevelopmental disorder. 
Results suggest the utility of screening for neurodevelopmental disorders in children with 
chronic pain, and may indicate insomnia, and skills related to psychological flexibility, such 
as attentional control and coping with demanding situations, as potential treatment targets 
to improve functioning and HRQoL. The results also suggest further research, to e.g. 
validate these findings in larger studies, evaluate the utility of tailored interventions, and 
examine a possibly shared neuropathophysiology of chronic pain and neurodevelopmental 
disorders, including dopamine function and sensory abnormalities. Furthermore, results call 
for studies that examine the relation between e.g. pain, insomnia, psychological 
inflexibility, and executive function in pediatric chronic pain. 
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